Fluorogenic Real-Time Reporters of DNA Repair by MGMT, a Clinical Predictor of Antitumor Drug Response
Common alkylating antitumor drugs, such as temozolomide, trigger their cytotoxicity by methylating the O6-position of guanosine in DNA. However, the therapeutic effect of these drugs is dampened by elevated levels of the DNA repair enzyme, O6-methylguanine DNA methyltransferase (MGMT), which directl...
Main Authors: | Beharry, Andrew A., Kool, Eric T., Samson, Leona D, Nagel, Zachary D. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2017
|
Online Access: | http://hdl.handle.net/1721.1/108301 https://orcid.org/0000-0002-7112-1454 |
Similar Items
-
Inter-individual variation in DNA repair capacity: A need for multi-pathway functional assays to promote translational DNA repair research
by: Nagel, Zachary D., et al.
Published: (2015) -
Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins
by: Bugni, J. M., et al.
Published: (2014) -
Fluorescence Sheds Light on DNA Damage, DNA Repair, and Mutations
by: Owiti, Norah Auma, et al.
Published: (2022) -
Balancing repair and tolerance of DNA damage caused by alkylating agents
by: Fu, Dragony, et al.
Published: (2014) -
DNA repair capacity in multiple pathways predicts chemoresistance in glioblastoma multiforme
by: Kitange, Gaspar J., et al.
Published: (2016)